GNT PHARMA introduces NEU2000 in hopes of treatment for strokes

GNT Pharma 기본형2

Hunger and disease cause great suffering in the world and everyone wants to live in a world without disease. Prevention is far more important than treatment when it comes to adult, lifestyle diseases. Habitual overeating can cause obesity and various adult diseases. Take strokes for example, where a stroke occurs when a vessel in the brain ruptures or is blocked by a blood clot. Stroke medical treatments work to either open the blockage or treat the rupture. Medical advances have greatly improved survival rates from stroke treatments during the last decade. But the chances of survival are even better if the stroke is identified and treated immediately.

GNT Pharma_┐¼▒╕┐°╡Θ


This section will outline some possible ways to prevent and treat a stroke. The good news is that 80 percent of all strokes are preventable. It starts with managing key risk factors, including high blood pressure, cigarette smoking, atrial fibrillation and physical inactivity. More than half of all strokes are caused by uncontrolled hypertension or high blood pressure, making it the most important risk factor to control. Medical treatments may be used to control high blood pressure and/or manage atrial fibrillation among high-risk patients. Those medicines include antiplatelet agents such as aspirin and anticoagulants, such as warfarin, interfere with the blood’s ability to clot and can play an important role in preventing strokes. Antihypertensives are medications that treat high blood pressure. Depending on the type of medication, they can lower blood pressure by opening the blood vessels, decreasing blood volume or decreasing the rate and/or force of heart contraction.

The race is on to find a cure for strokes and GNT PHARMA is one of the companies in South Korea that are striving to do so. This study reports dramatic results in restoring vision to patients who previously had no options for treatment. The new drug” NEU2000” provides one of the safest, most effective, most consistent clinical outcomes, and highest patient satisfaction, according to the hospital at the University of A-JU. GNT Pharma went through clinical trials and has shown the new drug, NEU2000, to be effective in slowing the rate of infection and superior effects on stroke. The new drug has gotten much attention of pharmaceutical companies and showing effective results.

GNT Pharma_┤δ╟Ñ╗τ┴°(1) GNT Pharma_┤δ╟Ñ╗τ┴°(2)

▲  GNT Pharma Co.,Ltd
▲  CEO : Byoung-Joo Gwag
▲  Email : [email protected]
▲  T : + 8231-8005-9910